Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

By Soeda Hiroshi   Shimodaira Hideki   Watanabe Mika   Suzuki Takao   Gamoh Makio   Mori Takahiro   Komine Keigo   Iwama Noriyuki   Kato Shunsuke   Ishioka Chikashi  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 670-677

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

By Lai Yuen-Liang  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1064-1069

Springer Publishing Company

Access to resources Recommend Favorite

A Novel PIK3CA Hotspot Mutation in Isfahanian Breast Cancer Patients

By Gharbi Sedigheh   Faghihi Mehri   Tavassoli Manoochehr  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 313-317

Informa Healthcare

Access to resources Recommend Favorite

Mutations of the PIK3CA gene in ovarian and breast cancer

By Bellacosa Alfonso  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 223-225

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 505-512

Spandidos Publications

Access to resources Recommend Favorite